Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
NRIX
Home
/
NRIX

NASDAQ
$15.95
$15.95

Overview

Price performance
Low
$14.78
High
$17.25
After hours. Last updated: Nov 4, 2026, 9:00 PM UTC
$
15.95
-9.87 (-38.23%)
Average, 50 days
$24.95
$20.24
Open
$17.16
Previous close
$25.82
52-week high
$28.23
Aug 19, 2026 (3 months ago)
52-week low
$11.67
Nov 7, 2025 (13 months ago)
36.68%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
1.74B
Volume
19 547 045
Total Return (3M)
-35.40%
Total Return (1Y)
30.10%
—
Sector
Healthcare
Links
Tags
Healthcare
Biotechnology
NASDAQ
US
Website
nurixtx.com
About
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-5948, an orally bioavailable BTK degrader, that is in Phase 2 clinical trials for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; NX-2127, an orally bioavailable Bruton’s tyrosine kinase (BTK) degrader, that is in Phase Phase 1a/1b clinical trials for the treatment of relapsed or refractory B-cell malignancies; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor, that is in Phase 1a/1b clinical trials to treat immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc. (Gilead), Sanofi S.A. (Sanofi), and Pfizer Inc. (Pfizer) for co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in Brisbane, California.

Frequently asked questions

NRIX · Nurix Therapeutics, Inc.

01What is Nurix Therapeutics, Inc. stock price today?

The current price of NRIX is $15.95 — it has decreased by 38.23% since the previous close. Data as of Nov 4, 2026.

02Is Nurix Therapeutics, Inc. stock price growing?

NRIX is down 40.71% over the past week, down 30.62% over the past month and up 30.10% over the past year. The price is below its 200-day moving average of $20.24.

03What is Nurix Therapeutics, Inc. market cap?

Nurix Therapeutics, Inc. has a market capitalization of $1.74B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04How volatile is NRIX stock?

In the latest trading session NRIX moved between $14.78 and $17.25, a range of 15.49% of its current price.

05What are NRIX stock 52-week high and low?

Over the past 52 weeks NRIX has traded between $11.67 and $28.23. The current price is 43.50% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.